Poster Session K - Theoretical and Translational Medicine 2.
Dr. Borsodi, Kinga, PhD
IWA1O0
Institute of Translational Medicine, Semmelweis University, Budapest, Hungary
06205740715
kingaborsodi@gmail.com
Bradykinin-induced detrusor muscle contraction involves both Gαq/11- and Gα12/13-coupled signaling
Kinga Borsodi1, Helga Balla1, Péter József Molnár2, Ádám Lénárt1, István Kenessey3, András Horváth4, Attila Keszthelyi4, Miklós Romics4, Attila Majoros4, Péter Nyirády4, Stefan Offermanns5, Zoltán Benyó6
1: Institute of Translational Medicine, Semmelweis University, Budapest, Hungary
2: Institute of Translational Medicine, Semmelweis University, Budapest, Hungary; Department of Urology, Semmelweis University, Budapest, Hungary
3: Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary
4: Department of Urology, Semmelweis University, Budapest, Hungary
5: Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany
6: Institute of Translational Medicine, Semmelweis University, Budapest, Hungary; HUN-REN-SU Cerebrovascular and Neurocognitive Diseases Research Group
Poszter
Poster Session K - Theoretical and Translational Medicine 2.
English
Theoretical and Translational Medicine
Introduction: Urinary bladder dysfunctins are getting more prevalent due to the aging population. The exact pathomechanisms of these disorders are often unclear, although there is accumulating evidence on the prominent role of inflammatory mediators. Accordingly, the nonapeptid bradykinin (BK) has been proposed in the regulation of bladder tone and implicated in the pathophysiology of detrusor overactivity. Our study aimed to elucidate the signaling pathways of BK-induced detrusor muscle contraction with the goal of identifying potential novel therapeutic targets of its disorders.
Methods: Experiments have been carried out on bladders isolated from wild-type or genetically modified [smooth muscle-specific inducible knockout (KO): Gαq/11-KO, Gα12/13-KO and constitutive KO: thromboxane prostanoid (TP) receptor-KO, cyclooxygenase-1 (COX-1)-KO] mice and on human bladder samples. Contractions of detrusor strips were measured by myography.
Results: BK induced concentration-dependent contractions in both murine and human bladders, which were independent of secondary release of acetylcholine, ATP, or prostanoid mediators. The B2 receptor antagonist HOE-140 markedly diminished, whereas the B1 receptor antagonist R-715 did not alter BK’s contractile effect in both species. Consistently with these findings, introducing the agonist of B2 but not B1 receptors induced contractions of the same magnitude as BK. Interestingly, both Gαq/11- and Gα12/13-KO murine bladders showed reduced response to BK, indicating that simultaneous activation of both pathways is required for the contraction. Furthermore, the Rho-kinase (ROCK) inhibitor Y-27632 markedly decreased contractions in both murine and human bladders.
Conclusion: These results indicate that BK evokes contractions in murine and human bladder smooth muscle, acting primarily on B2 receptors. Our data gained from the smooth muscle-specific Gαq/11-KO and Gα12/13-KO mouse bladders proved that Gαq/11-coupled and Gα12/13-RhoA-ROCK signaling appear to mediate the BK-induced contractions simultaneously. Furthermore, inhibition of ROCK reduces the contractions in both species, identifying this enzyme, together with B2 receptor, as potential targets for treating voiding disorders associated with enhanced BK release.
Funding: NKFIH K-125174, K-135683 and K-139230, EFOP-3.6.3-VEKOP-16-2017-00009 and ÚNKP-23-4-I grants
Semmelweis University
Zoltán Benyó, MD, PhD, DSc
Szabad
elfogadva
poszter
nem rendelkezett róla
4811
16:50
16:53